Impact of Phytochemicals on the Gastrointestinal Tract—Implications for Innovative Nutraceutical and Functional Food Development

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Phytochemicals and Human Health".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 244

Special Issue Editor

E-Mail Website
Guest Editor
Department of Basic Health Sciences, Faculty of Health Sciences, Rey Juan Carlos University (URJC), Alcorcón, 28922 Madrid, Spain
Interests: gastrointestinal motility; visceral pain; functional foods; cannabinoids; irritable bowel syndrome; nutraceuticals; enteric nervous system; brain–gut axis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Many plants have a long history of empiric use to treat gastrointestinal ailments, including nausea and emesis, diarrhea, and abdominal pain, among others. One interesting case is Cannabis sativa, which, in addition to hundreds of psychotropic and non-psychotropic phytocannabinoids (with different ratios in the different botanical varieties), contains many other interesting phytochemicals. Phytocannabinoids exert their actions through the modulation of the endocannabinoid system, which is broadly distributed in the gastrointestinal tract. However, the full spectrum of pharmacological actions on the gastrointestinal tract of Cannabis phytochemicals (isolated or in combination) is far from clear. Furthermore, gastrointestinal effects of these compounds may be modulated by actions on the brain (brain–gut axis), the immune system (immune–gut axis) or the endocrine system (endocrine–gut axis), among others. Phytochemicals found in Cannabis, their synthetic or semisynthetic analogues and other cannabinoid-like molecules (such as palmitoylethanolamide) may modify gastrointestinal tract functions and interfere with nutrition (improving or making it more difficult). Furthermore, many of the compounds found in the plant can be considered nutraceuticals and can thus be used for the development of new functional foods able to prevent or improve gastrointestinal symptoms.

Cannabis sativa is just one example of the many plants that can offer interesting molecules for the treatment of gastrointestinal and gut–brain conditions.

This Special Issue aims to collect original studies, reviews and meta-analyses that may help to fully understand the impact of Cannabis-derived products and extracts, phytocannabinoids, and other phytochemicals in Cannabis, as well as those from other plants on the gastrointestinal tract functions and dysfunctions. We hope this Special Issue will provide new information to help design better, holistic, balanced, and robust nutraceutical approaches for gastrointestinal conditions.

Prof. Dr. Raquel Abalo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • bowel
  • brain–gut axis
  • cannabis
  • cannabinoids
  • endocannabinoids
  • endocrine–gut axis
  • gastrointestinal tract
  • immune–gut axis
  • gut
  • phytocannabinoids
  • stomach

Published Papers

This special issue is now open for submission.
Back to TopTop